Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Valiant Laboratories IPO is a book build issue of ₹152.46 crores. The issue is entirely a fresh issue of 1.09 crore shares of ₹152.46 crore.
Valiant Laboratories IPO bidding started from Sep 27, 2023 and ended on Oct 3, 2023. The allotment for Valiant Laboratories IPO was finalized on Oct 5, 2023. The shares got listed on BSE, NSE on Oct 6, 2023.
Valiant Laboratories IPO price band is set at ₹140.00 per share . The lot size for an application is 105. The minimum amount of investment required by an retail is ₹13,965 (105 shares). The lot size investment for sNII is 14 lots (1,470 shares), amounting to ₹2,05,800, and for bNII, it is 69 lots (7,245 shares), amounting to ₹10,14,300.
Unistone Capital Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Valiant Laboratories IPO RHP for detailed Information.
| IPO Date | September 27, 2023 to October 3, 2023 |
| Listing Date | October 6, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹133 to ₹140 per share |
| Issue Price Final | ₹140 per share |
| Lot Size | 105 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,08,90,000 shares (aggregating up to ₹152.46 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Post Issue | 4,34,50,000 shares |
Valiant Laboratories IPO offers total 1,08,90,000 shares. Out of which 54,45,000 (50.00%) allocated to QIB, 21,78,030 (20.00%) allocated to QIB, 16,33,500 (15.00%) allocated to NII, 38,11,500 (35.00%) allocated to RII and 32,66,970 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 54,45,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 32,66,970 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 21,78,030 (20.00%) | NA |
| NII (HNI) Shares Offered | 16,33,500 (15.00%) | NA |
| − bNII > ₹10L | 10,89,000 (10.00%) | 740 |
| − sNII < ₹10L | 5,44,500 (5.00%) | 370 |
| Retail Shares Offered | 38,11,500 (35.00%) | 36,300 |
| Total Shares Offered | 1,08,90,000 (100.00%) |
Valiant Laboratories IPO raises ₹45.74 crore from anchor investors. Valiant Laboratories IPO Anchor bid date is September 26, 2023. Valiant Laboratories IPO Anchor Investors list
| Bid Date | September 26, 2023 |
| Shares Offered | 32,66,970 |
| Anchor Portion Size (In Cr.) | 45.74 |
| Anchor lock-in period end date for 50% shares (30 Days) | November 4, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | January 3, 2024 |
Valiant Laboratories IPO opens on September 27, 2023, and closes on October 3, 2023.
| IPO Open Date | Wed, Sep 27, 2023 |
| IPO Close Date | Tue, Oct 3, 2023 |
| Tentative Allotment | Thu, Oct 5, 2023 |
| Initiation of Refunds | Fri, Oct 6, 2023 |
| Credit of Shares to Demat | Fri, Oct 6, 2023 |
| Tentative Listing Date | Fri, Oct 6, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Oct 3, 2023 |
Investors can bid for a minimum of 105 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1,365 | ₹1,91,100 |
| S-HNI (Min) | 14 | 1,470 | ₹2,05,800 |
| S-HNI (Max) | 68 | 7,140 | ₹9,99,600 |
| B-HNI (Min) | 69 | 7,245 | ₹10,14,300 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 106.31 | 181.81 | 212.76 |
| Total Income | 183.78 | 293.47 | 338.77 |
| Profit After Tax | 30.59 | 27.50 | 29.00 |
| Net Worth | 88.58 | 71.46 | 100.49 |
| Reserves and Surplus | |||
| Total Borrowing | 0.35 | 60.68 | 59.40 |
The market capitalization of Valiant Laboratories IPO is ₹608.30 Cr.
| KPI | Values |
|---|---|
| ROE | 33.73% |
| ROCE | 22.76% |
| Debt/Equity | 0.59 |
| RoNW | 28.86% |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
[Dilip Davda] The company is in the business of manufacturing APIs and bulk drugs with a prime focus on widely used paracetamol. However, the company has posted declining trends for its PAT and RoCE margins for the reported periods. Based on FY23 earnings, the issue appears fully priced. Investors may park funds for medium to long-term rewards. Read detail review...
| Listing Date | October 6, 2023 |
| BSE Script Code | 543998 |
| NSE Symbol | VALIANTLAB |
| ISIN | INE0JWS01017 |
| Final Issue Price | ₹140 per share |
| BSE Listing Group | T |
Valiant Laboratories Ltd.
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
Mulund, Maharashtra
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Valiant Laboratories IPO is a main-board IPO of 1,08,90,000 equity shares of the face value of ₹10 aggregating up to ₹152.46 Crores. The issue is priced at ₹140 per share. The minimum order quantity is 105.
The IPO opens on September 27, 2023, and closes on October 3, 2023.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Valiant Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Valiant Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Valiant Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Valiant Laboratories IPO opens on September 27, 2023 and closes on October 3, 2023.
Valiant Laboratories IPO lot size is 105, and the minimum amount required for application is ₹14,700.
You can apply in Valiant Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Valiant Laboratories IPO will be done on Thursday, October 5, 2023, and the allotted shares will be credited to your demat account by Friday, October 6, 2023. Check the Valiant Laboratories IPO allotment status.
The Valiant Laboratories IPO listing date is on Friday, October 6, 2023.
Useful Articles
RHP